Povorcitinib — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12-26 in 2mo
ESTIMATED |
READOUT
A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Partici
Phase 3 · Hidradenitis Suppurativa (HS) |
INCY INCYTE CORP | Povorcitinib |
ClinicalTrials.gov ↗
✓ Source-checked 2026-11-04
Sponsor-projected date — can change
|